This is a table of type trigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
trigram | frequency |
---|---|
in patients with | 867 |
severe acute respiratory | 691 |
acute respiratory syndrome | 665 |
patients with severe | 485 |
the treatment of | 285 |
as well as | 283 |
the use of | 271 |
of patients with | 262 |
patients with covid | 254 |
respiratory syndrome coronavirus | 236 |
of severe acute | 220 |
the presence of | 206 |
the risk of | 199 |
respiratory distress syndrome | 184 |
acute respiratory distress | 172 |
all rights reserved | 169 |
is associated with | 166 |
of the disease | 164 |
the development of | 163 |
the severity of | 153 |
clinical signs of | 150 |
the most common | 143 |
one of the | 143 |
in the treatment | 138 |
with severe covid | 137 |
intensive care unit | 132 |
with severe acute | 129 |
this article is | 126 |
is protected by | 123 |
protected by copyright | 122 |
article is protected | 122 |
critically ill patients | 120 |
according to the | 120 |
due to the | 119 |
associated with severe | 118 |
for the treatment | 118 |
based on the | 117 |
risk factors for | 112 |
be associated with | 109 |
there is no | 109 |
of severe covid | 109 |
because of the | 109 |
associated with a | 106 |
mg kg iv | 104 |
clinical characteristics of | 104 |
can be used | 101 |
the role of | 100 |
the pathogenesis of | 100 |
are associated with | 99 |
for patients with | 95 |
in cases of | 95 |
the diagnosis of | 93 |
of the patients | 93 |
world health organization | 93 |
a systematic review | 91 |
the incidence of | 91 |
the management of | 91 |
associated with the | 90 |
a patient with | 89 |
in severe covid | 89 |
cd t cells | 89 |
been shown to | 88 |
in addition to | 87 |
the course of | 86 |
have been reported | 85 |
it has been | 82 |
the majority of | 81 |
has granted medrxiv | 79 |
display the preprint | 79 |
medrxiv a license | 79 |
a license to | 79 |
license to display | 79 |
the preprint in | 79 |
granted medrxiv a | 79 |
to display the | 79 |
who has granted | 79 |
of novel coronavirus | 78 |
hospitalized patients with | 77 |
a variety of | 77 |
systematic review and | 77 |
treatment of severe | 76 |
of liver failure | 75 |
the author funder | 75 |
the time of | 75 |
is the author | 75 |
in children with | 75 |
the number of | 75 |
in the early | 75 |
as a result | 75 |
with severe hepatitis | 74 |
and treatment of | 74 |
was associated with | 74 |
in this study | 74 |
the patient is | 74 |
there is a | 73 |
in the severe | 73 |
the absence of | 71 |
of the sars | 71 |
in order to | 70 |
in critically ill | 69 |
has been reported | 69 |
increased risk of | 69 |
which was not | 68 |
the efficacy of | 68 |
an increase in | 67 |
with novel coronavirus | 67 |
the occurrence of | 66 |
a result of | 66 |
in some cases | 66 |
in the first | 65 |
depending on the | 65 |
a number of | 65 |
in hong kong | 64 |
related to the | 64 |
be used to | 64 |
should be considered | 64 |
preprint in perpetuity | 64 |
can lead to | 64 |
patients infected with | 63 |
review and meta | 63 |
there was no | 63 |
at the time | 63 |
in severe cases | 62 |
the effect of | 62 |
patients with acute | 62 |
clinical features of | 62 |
is the most | 62 |
not certified by | 61 |
severe falciparum malaria | 61 |
certified by peer | 61 |
risk of severe | 61 |
with coronavirus disease | 61 |
by peer review | 61 |
the copyright holder | 61 |
was not certified | 61 |
in a patient | 61 |
a total of | 61 |
mg kg po | 60 |
acute liver failure | 60 |
the onset of | 60 |
of hepatitis b | 60 |
the need for | 60 |
middle east respiratory | 59 |
copyright holder for | 58 |
a novel coronavirus | 58 |
holder for this | 58 |
east respiratory syndrome | 57 |
the level of | 57 |
of coronavirus disease | 57 |
the united states | 56 |
treatment of covid | 56 |
o o f | 55 |
respiratory syndrome in | 55 |
l p r | 55 |
r o o | 55 |
is based on | 55 |
u r n | 55 |
p r e | 55 |
can be administered | 55 |
children with severe | 55 |
been reported in | 55 |
role in the | 55 |
o u r | 55 |
n a l | 55 |
p r o | 55 |
j o u | 55 |
hepatitis b virus | 55 |
r n a | 55 |
patients in the | 55 |
a l p | 55 |
patients with cirrhosis | 54 |
this version posted | 54 |
the immune system | 54 |
the severe acute | 54 |
disseminated intravascular coagulation | 54 |
and septic shock | 53 |
of the patient | 53 |
patients with chronic | 53 |
the patients with | 53 |
an important role | 52 |
need to be | 52 |
a history of | 52 |
patients with coronavirus | 52 |
the impact of | 52 |
the severe group | 52 |
it is important | 52 |
in the absence | 52 |
to determine the | 51 |
ill patients with | 51 |
risk factor for | 51 |
see section on | 51 |
in combination with | 51 |
on the other | 51 |
retrospective cohort study | 51 |
infected with sars | 51 |
can also be | 51 |
patients treated with | 51 |
should be performed | 50 |
appears to be | 50 |
of severe malaria | 50 |
in most cases | 50 |
in the liver | 50 |
has also been | 50 |
been associated with | 49 |
is important to | 49 |
of sars coronavirus | 49 |
in the united | 49 |
of convalescent plasma | 49 |
the expression of | 49 |
shown to be | 49 |
novel coronavirus in | 49 |
acute lung injury | 49 |
should not be | 49 |
associated with increased | 49 |
has been shown | 49 |
the lack of | 49 |
may not be | 48 |
can result in | 48 |
of the virus | 48 |
analysis of the | 48 |
a combination of | 48 |
severe and critical | 48 |
of the risk | 47 |
the results of | 47 |
most of the | 47 |
the other hand | 47 |
morbidity and mortality | 47 |
the basis of | 46 |
in of patients | 46 |
central nervous system | 46 |
the degree of | 46 |
management of severe | 46 |
the cause of | 46 |
the form of | 46 |
for this preprint | 46 |
patients with liver | 46 |
found to be | 46 |
of patients infected | 46 |
more likely to | 46 |
such as the | 45 |
for the diagnosis | 45 |
fever with thrombocytopenia | 45 |
no reuse allowed | 45 |
allowed without permission | 45 |
in the form | 45 |
has not been | 45 |
included in the | 45 |
may be associated | 45 |
factors associated with | 45 |
reuse allowed without | 45 |
high levels of | 44 |
may be a | 44 |
severity of covid | 44 |
with severe malaria | 44 |
in the pathogenesis | 44 |
fda labels for | 44 |
efficacy and safety | 44 |
the two groups | 44 |
is one of | 44 |
to assess the | 44 |
and safety of | 44 |
understanding of the | 44 |
perform orogastric lavage | 44 |
the effects of | 44 |
to evaluate the | 44 |
severe fever with | 44 |
patients with sars | 43 |
diagnosis and treatment | 43 |
and can be | 43 |
with thrombocytopenia syndrome | 43 |
to be a | 43 |
in a study | 43 |
of critically ill | 43 |
with severe pneumonia | 43 |
h n influenza | 43 |
the levels of | 43 |
tumor necrosis factor | 43 |
for treatment of | 43 |
the most important | 42 |
in the non | 42 |
the present study | 42 |
important role in | 42 |
preprint this version | 42 |
between the two | 42 |
of this study | 42 |
severity of the | 42 |
during the first | 42 |
is difficult to | 42 |
is an important | 42 |
this preprint this | 42 |
in the lungs | 42 |
to reduce the | 42 |
in these patients | 42 |
systemic inflammatory response | 41 |
of activated charcoal | 41 |
it should be | 41 |
chronic hepatitis b | 41 |
the production of | 41 |
severe sepsis and | 41 |
with or without | 41 |
in severe acute | 41 |
there was a | 41 |
patients with a | 41 |
this study was | 41 |
of the most | 41 |
in sars patients | 40 |
of hospitalized patients | 40 |
activation of the | 40 |
in severe hepatitis | 40 |
pneumonia in wuhan | 40 |
in hospitalized patients | 40 |
needs to be | 40 |
caused by the | 40 |
compared to the | 40 |
is characterized by | 40 |
have shown that | 40 |
if the patient | 39 |
to patients with | 39 |
the intensive care | 39 |
the importance of | 39 |
changes in the | 39 |
the context of | 39 |
the early stage | 39 |
with acute respiratory | 39 |
patients admitted to | 39 |
the possibility of | 39 |
were reported in | 39 |
a retrospective cohort | 39 |
of cases of | 38 |
were associated with | 38 |
chronic liver failure | 38 |
of severe hepatitis | 38 |
used in the | 38 |
involved in the | 38 |
of the following | 38 |
be treated with | 38 |
and it is | 38 |
a decrease in | 37 |
of hepatic encephalopathy | 37 |
to mg kg | 37 |
sepsis and septic | 37 |
have also been | 37 |
cytokine release syndrome | 37 |
in which the | 37 |
have been shown | 37 |
of children with | 37 |
years of age | 37 |
can be performed | 37 |
review of the | 37 |
immune response to | 37 |
in terms of | 37 |
novel coronavirus pneumonia | 37 |
the end of | 36 |
of the study | 36 |
than in the | 36 |
disease severity and | 36 |
higher risk of | 36 |
t cells in | 36 |
patients with novel | 36 |
the age of | 36 |
likely to be | 36 |
should be used | 36 |
was used to | 36 |
a minimum of | 35 |
should be given | 35 |
the amount of | 35 |
in the patients | 35 |
studies have shown | 35 |
a recent study | 35 |
of a novel | 35 |
the case of | 35 |
with severe disease | 35 |
used to treat | 35 |
of the immune | 35 |
the proportion of | 35 |
and outcome of | 35 |
kg po q | 35 |
in the management | 35 |
red blood cells | 35 |
admitted to the | 35 |
be used in | 35 |
the relationship between | 35 |
the formation of | 34 |
on the basis | 34 |
upper respiratory tract | 34 |
which may be | 34 |
may be necessary | 34 |
in the context | 34 |
there are no | 34 |
may also be | 34 |
moderate to severe | 34 |
appear to be | 34 |
innate immune response | 34 |
and cd t | 34 |
t cell responses | 34 |
for severe covid | 34 |
cd and cd | 34 |
part of the | 34 |
and should be | 34 |
and management of | 34 |
patients with mild | 34 |
may be required | 33 |
in the case | 33 |
responses to sars | 33 |
and risk factors | 33 |
chronic liver disease | 33 |
of the severe | 33 |
falciparum malaria in | 33 |
type i ifn | 33 |
version posted may | 33 |
be divided into | 33 |
acute exacerbation of | 33 |
be related to | 33 |
randomized controlled trial | 33 |
end of the | 33 |
the spike protein | 33 |
the detection of | 33 |
was found to | 33 |
in the blood | 33 |
the administration of | 33 |
acute respiratory failure | 33 |
increase the risk | 33 |
lower respiratory tract | 33 |
large number of | 33 |
to be associated | 33 |
were found to | 33 |
in our study | 33 |
contribute to the | 33 |
may lead to | 32 |
be due to | 32 |
in many cases | 32 |
the cytokine storm | 32 |
the gastrointestinal tract | 32 |
to determine whether | 32 |
cases of severe | 32 |
clinical and laboratory | 32 |
as soon as | 32 |
factors for severe | 32 |
is caused by | 32 |
of clinical signs | 32 |
a group of | 32 |
features of patients | 32 |
the activity of | 32 |
of the clinical | 32 |
course of the | 32 |
levels of il | 32 |
viral load in | 32 |
results of a | 32 |
the first hours | 32 |
with disease severity | 32 |
that patients with | 32 |
by administration of | 32 |
in the course | 32 |
the rate of | 31 |
other causes of | 31 |
is a common | 31 |
the innate immune | 31 |
observed in the | 31 |
in intensive care | 31 |
randomized clinical trial | 31 |
in dogs and | 31 |
play an important | 31 |
acute renal failure | 31 |
cause of the | 31 |
of these patients | 31 |
high risk of | 31 |
in the presence | 31 |
evaluation of the | 31 |
the s protein | 30 |
the activation of | 30 |
the world health | 30 |
be used as | 30 |
which can be | 30 |
in the present | 30 |
proportion of patients | 30 |
were included in | 30 |
should be treated | 30 |
treatment consists of | 30 |
the novel coronavirus | 30 |
pediatric intensive care | 30 |
fresh frozen plasma | 30 |
for a minimum | 30 |
a retrospective study | 30 |
severe and non | 30 |
be caused by | 30 |
mild to moderate | 30 |
invasive mechanical ventilation | 30 |
that there is | 30 |
higher in the | 30 |
macrophage activation syndrome | 30 |
the immune response | 30 |
has been used | 30 |
infected with novel | 29 |
shortness of breath | 29 |
can be divided | 29 |
based on clinical | 29 |
in the study | 29 |
convalescent plasma therapy | 29 |
may be present | 29 |
the release of | 29 |
the fact that | 29 |
the association between | 29 |
cells in the | 29 |
what is the | 29 |
in response to | 29 |
coronavirus disease in | 29 |
in some patients | 29 |
some of the | 29 |
of the world | 29 |
outbreak of severe | 29 |
early stage of | 29 |
and in the | 29 |
there were no | 29 |
in horses with | 29 |
if there is | 29 |
in the icu | 29 |
obstructive pulmonary disease | 29 |
of severe disease | 29 |
the sars coronavirus | 29 |
due to a | 29 |
associated with an | 29 |
and development of | 28 |
clinical manifestations of | 28 |
has been described | 28 |
clinical features and | 28 |
the prevalence of | 28 |
an increased risk | 28 |
respiratory syncytial virus | 28 |
in case of | 28 |
a risk factor | 28 |
reported to be | 28 |
more than of | 28 |
of the liver | 28 |
depends on the | 28 |
the patient has | 28 |
have not been | 28 |
and mortality in | 28 |
among patients with | 28 |
to be the | 28 |
been reported to | 28 |
seems to be | 28 |
followed by administration | 28 |
development of severe | 28 |
elevated levels of | 28 |
phase of the | 28 |
syndrome coronavirus infection | 28 |
a study of | 28 |
for use in | 28 |
number of patients | 28 |
found in the | 28 |
administration of activated | 27 |
polymerase chain reaction | 27 |
chronic obstructive pulmonary | 27 |
the duration of | 27 |
of severe and | 27 |
immune response in | 27 |
in relation to | 27 |
it is not | 27 |
with severe respiratory | 27 |
article this article | 27 |
during the course | 27 |
type i interferon | 27 |
with severe sepsis | 27 |
be used for | 27 |
showed that the | 27 |
po q h | 27 |
should be avoided | 27 |
for severe acute | 27 |
accepted article this | 27 |
coronavirus in wuhan | 27 |
symptoms such as | 27 |
with cerebral malaria | 27 |
to have a | 27 |
high mortality rate | 27 |
was significantly higher | 27 |
a large number | 27 |
inflammatory response syndrome | 27 |
are needed to | 27 |
of sars patients | 27 |
that have been | 27 |
protein of sars | 27 |
also can be | 27 |
the clinical characteristics | 27 |
study was to | 26 |
from patients with | 26 |
severe hepatitis patients | 26 |
m a n | 26 |
in the group | 26 |
severe malaria in | 26 |
health care workers | 26 |
n u s | 26 |
and may be | 26 |
white blood cell | 26 |
significantly associated with | 26 |
dogs and cats | 26 |
development of a | 26 |
recurrent airway obstruction | 26 |
for the management | 26 |
t cells and | 26 |
a n u | 26 |
i p t | 26 |
clinical course and | 26 |
u s c | 26 |
in the lung | 26 |
severe hepatitis b | 26 |
no evidence of | 26 |
s c r | 26 |
syndrome in hong | 26 |
risk of death | 26 |
have been described | 26 |
a role in | 26 |
may result in | 26 |
in patients who | 26 |
response to sars | 26 |
the progression of | 26 |
coronavirus associated with | 26 |
the aim of | 26 |
thought to be | 26 |
in clinical practice | 26 |
in severe patients | 26 |
r i p | 26 |
patients who were | 26 |
a diagnosis of | 26 |
the peripheral blood | 26 |
c r i | 26 |
in the setting | 25 |
prevention and treatment | 25 |
study of patients | 25 |
intravenous crystalloid fluids | 25 |
used as a | 25 |
in severe malaria | 25 |
pediatric patients with | 25 |
increased levels of | 25 |
to prevent further | 25 |
no significant difference | 25 |
treatment of patients | 25 |
adult patients with | 25 |
cytokines and chemokines | 25 |
of the infection | 25 |
with severe cap | 25 |
may contribute to | 25 |
neutrophil extracellular traps | 25 |
has been associated | 25 |
around the world | 25 |
the patient with | 25 |
associated with poor | 25 |
any of the | 25 |
disease in china | 25 |
it is difficult | 25 |
intravenous fluids to | 25 |
were treated with | 25 |
disease caused by | 25 |
used as an | 25 |
the coronavirus disease | 25 |
acute and chronic | 25 |
considered to be | 25 |
well as the | 25 |
a prospective study | 25 |
higher levels of | 24 |
that can be | 24 |
there may be | 24 |
the ability of | 24 |
disease control and | 24 |
significantly higher in | 24 |
play a role | 24 |
cause of death | 24 |
innate immune system | 24 |
similar to those | 24 |
and clinical characteristics | 24 |
the incubation period | 24 |
of chronic hepatitis | 24 |
the diagnosis and | 24 |
patients with sepsis | 24 |
of death in | 24 |
cases of covid | 24 |
used for the | 24 |
of disease severity | 24 |
at the same | 24 |
increase in the | 24 |
control and prevention | 24 |
novel coronavirus disease | 24 |
epithelial cells and | 24 |
intensive care units | 24 |
damage to the | 24 |
multiple organ dysfunction | 24 |
caused by a | 24 |
associated with disease | 24 |
were observed in | 24 |
the prognosis of | 24 |
a report of | 24 |
it is possible | 24 |
can be considered | 24 |
patients with moderate | 24 |
the setting of | 24 |
for disease control | 24 |
patients should be | 24 |
outcome of severe | 23 |
a reduction in | 23 |
d m a | 23 |
administer intravenous fluids | 23 |
e p t | 23 |
a c c | 23 |
of severe pneumonia | 23 |
in pediatric patients | 23 |
signs associated with | 23 |
with a high | 23 |
in peripheral blood | 23 |
the outcome of | 23 |
assessment report of | 23 |
ml kg hour | 23 |
the risk factors | 23 |
found to have | 23 |
fluids to maintain | 23 |
a review of | 23 |
the influence of | 23 |
controlled trial of | 23 |
should be administered | 23 |
shown in table | 23 |
the animal is | 23 |
early diagnosis of | 23 |
in vitro studies | 23 |
of the covid | 23 |
there have been | 23 |
is made available | 23 |
license it is | 23 |
the patient should | 23 |
it is made | 23 |
factors for mortality | 23 |
e d m | 23 |
t e d | 23 |
international license it | 23 |
respiratory failure and | 23 |
in the same | 23 |
the surface of | 23 |
syndrome in children | 23 |
and mechanical ventilation | 23 |
made available under | 23 |
for the prevention | 23 |
in adult patients | 23 |
a consequence of | 23 |
available under a | 23 |
p t e | 23 |
is able to | 23 |
has been suggested | 23 |
the mortality rate | 23 |
severe cases of | 23 |
the respiratory tract | 23 |
of sars in | 23 |
the clinical course | 23 |
it may be | 23 |
transmission of sars | 23 |
and so on | 23 |
c e p | 23 |
in a recent | 23 |
followed by a | 23 |
severe maternal morbidity | 23 |
c c e | 23 |
the pathophysiology of | 22 |
of respiratory distress | 22 |
to identify the | 22 |
small number of | 22 |
similar to that | 22 |
one or more | 22 |
was reported in | 22 |
the skin and | 22 |
can occur in | 22 |
signs and symptoms | 22 |
onset of symptoms | 22 |
of the lung | 22 |
characteristics of patients | 22 |
patients who are | 22 |
the patient and | 22 |
and those with | 22 |
of t cells | 22 |
found that the | 22 |
tip of the | 22 |
cd t cell | 22 |
the application of | 22 |
have been used | 22 |
the patients were | 22 |
before and after | 22 |
it is a | 22 |
all of the | 22 |
reserved this article | 22 |
differences in the | 22 |
response to the | 22 |
rights reserved this | 22 |
clinical signs are | 22 |
multiple organ failure | 22 |
cause of severe | 22 |
the study of | 22 |
closely related to | 22 |
the spread of | 22 |
with respiratory failure | 22 |
can be found | 22 |
clinical signs associated | 22 |
there has been | 22 |
a higher risk | 22 |
be considered as | 22 |
clinical management of | 22 |
a lack of | 22 |
the systemic circulation | 22 |
treatment of sars | 22 |
of the underlying | 22 |
is not available | 22 |
patients with he | 22 |
the process of | 22 |
when compared to | 21 |
th and th | 21 |
of the drug | 21 |
who did not | 21 |
is less than | 21 |
management of patients | 21 |
difference in the | 21 |
in those with | 21 |
pathogenesis of severe | 21 |
detection of sars | 21 |
have been developed | 21 |
in african children | 21 |
or perform orogastric | 21 |
of mechanical ventilation | 21 |
severity of disease | 21 |
it is also | 21 |
were found in | 21 |
the disease and | 21 |
the early phase | 21 |
be useful in | 21 |
in vitro and | 21 |
in the respiratory | 21 |
to maintain hydration | 21 |
plasmodium falciparum malaria | 21 |
influenza a virus | 21 |
the same time | 21 |
may be considered | 21 |
with severe asthma | 21 |
until the patient | 21 |
congestive heart failure | 21 |
in accordance with | 21 |
to ml kg | 21 |
of a patient | 21 |
a series of | 21 |
than that of | 21 |
the site of | 21 |
the existence of | 21 |
intestinal epithelial cells | 21 |
is necessary to | 21 |
as compared to | 21 |
angiotensin converting enzyme | 21 |
aspect of the | 21 |
can be observed | 21 |
in recent years | 21 |
majority of patients | 21 |
innate and adaptive | 21 |
clinical characteristics and | 21 |
the complement system | 21 |
of inflammatory cytokines | 21 |
of the coronavirus | 21 |
the mechanism of | 21 |
death in patients | 21 |
inflammatory cytokines and | 21 |
children and adults | 21 |
the tip of | 21 |
characteristics of coronavirus | 20 |
in infants and | 20 |
in adults with | 20 |
so that the | 20 |
of type i | 20 |
the viral load | 20 |
in severe and | 20 |
adults and children | 20 |
with liver failure | 20 |
severe respiratory distress | 20 |
the type of | 20 |
exacerbation of hepatitis | 20 |
of the viral | 20 |
a h n | 20 |
in both groups | 20 |
to be more | 20 |
days after onset | 20 |
on the use | 20 |
independent risk factor | 20 |
level of the | 20 |
is more common | 20 |
mechanical ventilation and | 20 |
of lopinavir ritonavir | 20 |
with chronic hepatitis | 20 |
as a potential | 20 |
severity of illness | 20 |
make sure that | 20 |
in all patients | 20 |
during the early | 20 |
of asthma exacerbations | 20 |
in animal models | 20 |
the prevention and | 20 |
children with covid | 20 |
and acute respiratory | 20 |
in the brain | 20 |
it can be | 20 |
role of the | 20 |
liver and kidney | 20 |
clinical course of | 20 |
significantly higher than | 20 |
on clinical signs | 20 |
patients with hepatitis | 20 |
lead to a | 20 |
management of the | 20 |
a new coronavirus | 20 |
was observed in | 20 |
associated with covid | 20 |
early in the | 20 |
with convalescent plasma | 20 |
logistic regression analysis | 20 |
in the development | 20 |
more common in | 20 |
patients who had | 20 |
of the first | 20 |
the acute phase | 20 |
of the children | 20 |
on mental health | 20 |
and the development | 20 |
were admitted to | 20 |
within the first | 20 |
results of the | 20 |
the result of | 20 |
addition to the | 20 |
patients with pidd | 19 |
in those patients | 19 |
of severe sepsis | 19 |
the first week | 19 |
to the development | 19 |
is not clear | 19 |
infected pneumonia in | 19 |
of the catheter | 19 |
the anterior chamber | 19 |
may be the | 19 |
critically ill covid | 19 |
severe cap group | 19 |
the patient to | 19 |
is likely to | 19 |
the inflammatory response | 19 |
novel coronavirus from | 19 |
no significant differences | 19 |
therapy in severe | 19 |
sars coronavirus infection | 19 |
there is an | 19 |
associated with higher | 19 |
of choice for | 19 |
is due to | 19 |
adults with severe | 19 |
the concentration of | 19 |
in the usa | 19 |
wide range of | 19 |
blood cell count | 19 |
the central nervous | 19 |
and the patient | 19 |
west nile virus | 19 |
patients with cerebral | 19 |
may be observed | 19 |
capillary refill time | 19 |
can cause severe | 19 |
be administered to | 19 |
be considered in | 19 |
of proinflammatory cytokines | 19 |
characteristics of hospitalized | 19 |
data suggest that | 19 |
with liver cirrhosis | 19 |
the extent of | 19 |
thrombocytopenia syndrome virus | 19 |
in treatment of | 19 |
to improve the | 19 |
during the covid | 19 |
in a large | 19 |
aseptically scrub the | 19 |
half of the | 19 |
and critical patients | 19 |
in the plasma | 19 |
clinical signs and | 19 |
the general population | 19 |
days after the | 19 |
in falciparum malaria | 19 |
and there is | 19 |
mild and severe | 19 |
the efficacy and | 19 |
observed in patients | 19 |
response in patients | 19 |
we found that | 19 |
should also be | 19 |
soon as possible | 19 |
it was reported | 19 |
of them were | 19 |
to severe covid | 19 |
detected in the | 19 |
and administration of | 19 |
the length of | 19 |
to occur in | 19 |
for the development | 19 |
and outcomes of | 19 |
cov and sars | 19 |
such as il | 19 |
surface of the | 19 |
a poor prognosis | 19 |
responsible for the | 19 |
severe respiratory failure | 19 |
diffuse alveolar damage | 19 |
risk of developing | 19 |
in contrast to | 19 |
may be an | 19 |
iv q h | 19 |
correlated with the | 19 |
the volume of | 19 |
the identification of | 18 |
of patients and | 18 |
is possible that | 18 |
the clinical manifestations | 18 |
the virus to | 18 |
in the emergency | 18 |
considered as a | 18 |
of the two | 18 |
are similar to | 18 |
induce emesis or | 18 |
the ema assessment | 18 |
cases have been | 18 |
the hpa axis | 18 |
the binding of | 18 |
for the study | 18 |
patients with the | 18 |
cells of the | 18 |
in the majority | 18 |
of cd t | 18 |
course of illness | 18 |
cov and mers | 18 |
been observed in | 18 |
can be caused | 18 |
is defined as | 18 |
the bone marrow | 18 |
administration of a | 18 |
on the first | 18 |
treatment of choice | 18 |
the emergency department | 18 |
under a is | 18 |
the source of | 18 |
failure caused by | 18 |
patients hospitalized with | 18 |
viral load and | 18 |
in another study | 18 |
with severe leukopenia | 18 |
did not show | 18 |
was no significant | 18 |
in association with | 18 |
ema assessment report | 18 |
been described in | 18 |
severe respiratory disease | 18 |
the combination of | 18 |
immune responses to | 18 |
of the host | 18 |
group of patients | 18 |
all patients with | 18 |
be given to | 18 |
regions of the | 18 |
hydroxychloroquine and azithromycin | 18 |
outcomes of patients | 18 |
of this disease | 18 |
size of the | 18 |
coronavirus spike protein | 18 |
infection in patients | 18 |
of the needle | 18 |
positively correlated with | 18 |
in the peripheral | 18 |
patient with a | 18 |
the control group | 18 |
of the blood | 18 |
in the second | 18 |
quality of life | 18 |
within hours of | 18 |
guidelines for the | 18 |
number of cases | 18 |
for mechanical ventilation | 18 |
of patients in | 18 |
associated with acute | 18 |
the patient in | 18 |
patient should be | 18 |
pathogenesis of covid | 18 |
made based on | 18 |
patients with type | 18 |
the emergence of | 18 |
in the intensive | 18 |
a is the | 18 |
with severe falciparum | 18 |
septic shock and | 18 |
emesis or perform | 18 |
serum levels of | 18 |
the prognosis is | 18 |
at least one | 18 |
of hydroxychloroquine in | 18 |
with severe ea | 18 |
functional receptor for | 18 |
in a small | 18 |
are more likely | 18 |
with regard to | 18 |
onset of illness | 18 |
in the ema | 18 |
at the end | 18 |
refers to the | 18 |
an intravenous catheter | 18 |
be observed in | 18 |
not associated with | 18 |
suggest that the | 18 |
induction of emesis | 18 |
is known to | 18 |
for at least | 18 |
for mortality of | 18 |
stage of the | 18 |
as part of | 18 |
early stages of | 18 |
sars and mers | 18 |
and patients with | 18 |
decrease in the | 18 |
and liver failure | 18 |
the effectiveness of | 18 |
is not a | 18 |
a randomized clinical | 18 |
course and risk | 17 |
up to of | 17 |
of the literature | 17 |
inpatients with covid | 17 |
and the severity | 17 |
in the future | 17 |
cells in patients | 17 |
in the serum | 17 |
signs of toxicity | 17 |
during the acute | 17 |
to the icu | 17 |
mortality in patients | 17 |
placement of a | 17 |
high level of | 17 |
was reported that | 17 |
this type of | 17 |
the ability to | 17 |
under general anesthesia | 17 |
of severe asthma | 17 |
similar to the | 17 |
the function of | 17 |
some of these | 17 |
stages of the | 17 |
the prevention of | 17 |
malaria in children | 17 |
the clinical and | 17 |
a high mortality | 17 |
a small amount | 17 |
susceptibility to severe | 17 |
of respiratory failure | 17 |
epidemiological and clinical | 17 |
in endemic areas | 17 |
reduction in the | 17 |
this suggests that | 17 |
were significantly higher | 17 |
of adult inpatients | 17 |
group than in | 17 |
in the late | 17 |
of the fluid | 17 |
immune responses in | 17 |
mortality of adult | 17 |
many of the | 17 |
coronavirus in patients | 17 |
are the most | 17 |
any patient with | 17 |
more than one | 17 |
and renal failure | 17 |
of the s | 17 |
been found to | 17 |
may be related | 17 |
to prevent the | 17 |
but it is | 17 |
in the past | 17 |
of the small | 17 |
adult inpatients with | 17 |
in the field | 17 |
adaptive immune responses | 17 |
reactive oxygen species | 17 |
constant rate infusion | 17 |
infection with sars | 17 |
of the innate | 17 |
the acute respiratory | 17 |
an analysis of | 17 |
and severe covid | 17 |
the mortality of | 17 |
is the first | 17 |
is also a | 17 |
chronic liver diseases | 17 |
to the sars | 17 |
is used to | 17 |
clinical trials are | 17 |
been reported that | 17 |
also associated with | 17 |
stage liver disease | 17 |
to be effective | 17 |
small amount of | 17 |
a range of | 17 |
severely ill covid | 17 |
in the body | 17 |
of the lungs | 17 |
treatment should be | 17 |
of chronic liver | 17 |
severely ill patients | 17 |
partial pressure of | 17 |
side effects of | 17 |
systematic review of | 17 |
which is a | 17 |
of the body | 17 |
ace and tmprss | 17 |
by severe acute | 17 |
the ratio of | 17 |
pandemic influenza a | 17 |
the frequency of | 17 |
compared with the | 17 |
remains to be | 17 |
complete blood count | 17 |
aim of this | 17 |
suggests that the | 17 |
novel coronavirus associated | 17 |
and has been | 17 |
significant difference in | 17 |
on the surface | 17 |
better understanding of | 17 |
severe disease and | 17 |
and young children | 17 |
of severe illness | 17 |
malaria should be | 17 |
for detection of | 17 |
kg iv q | 17 |
are likely to | 17 |
of peripheral blood | 17 |
this study is | 17 |
critically ill children | 17 |
the early stages | 17 |
function of the | 17 |
host immune responses | 17 |
symptoms and comorbidities | 17 |
characteristics of cases | 17 |
the patient was | 17 |
and severity of | 17 |
of clinical trials | 17 |
in the clinical | 17 |
the clinical features | 17 |
that has been | 16 |
plasma therapy in | 16 |
time of presentation | 16 |
the analysis of | 16 |
is similar to | 16 |
of immune response | 16 |
can be placed | 16 |
and pathogenesis of | 16 |
led to the | 16 |
is thought to | 16 |
may play a | 16 |
of intensive care | 16 |
with increased risk | 16 |
the toxic dose | 16 |
with falciparum malaria | 16 |
observed that the | 16 |
was found in | 16 |
associated with high | 16 |
for more than | 16 |
the underlying cause | 16 |
the liver and | 16 |
identification of a | 16 |
determined by the | 16 |
a dose of | 16 |
is related to | 16 |
memory b cells | 16 |
was defined as | 16 |
acute kidney injury | 16 |
a descriptive study | 16 |
diagnosis and management | 16 |
dengue shock syndrome | 16 |
examination of the | 16 |
further studies are | 16 |
the respiratory system | 16 |
the normal range | 16 |
in view of | 16 |
and the presence | 16 |
a case of | 16 |
as a consequence | 16 |
be helpful in | 16 |
be involved in | 16 |
patients who have | 16 |
after the onset | 16 |
risk for severe | 16 |
with the development | 16 |
adaptive immune response | 16 |
a urinary catheter | 16 |
antibody responses to | 16 |
every to hours | 16 |
to increase the | 16 |
and adaptive immune | 16 |
factors such as | 16 |
severe pneumonia in | 16 |
in young children | 16 |
the disease is | 16 |
studies are needed | 16 |
in children and | 16 |
patients and methods | 16 |
and risk of | 16 |
to control the | 16 |
risk factors associated | 16 |
the difference in | 16 |
severe cases had | 16 |
incubation period of | 16 |
in a short | 16 |
base and electrolyte | 16 |
of the novel | 16 |
patients with hbv | 16 |
to investigate the | 16 |
to severe acute | 16 |
to the severity | 16 |
characterization of the | 16 |
bronchoalveolar lavage fluid | 16 |
of severe cases | 16 |
was shown to | 16 |
of patients who | 16 |
cases in which | 16 |
kg q h | 16 |
to days after | 16 |
n severe vs | 16 |
moderate and severe | 16 |
use of a | 16 |
to the virus | 16 |
in the intestine | 16 |
inflammatory airway disease | 16 |
hepatitis b and | 16 |
are shown in | 16 |
that in the | 16 |
in rhesus macaques | 16 |
independent risk factors | 16 |
a period of | 16 |
horses with severe | 16 |
use of corticosteroids | 16 |
in clinical trials | 16 |
a wide range | 16 |
with hepatitis b | 16 |
infants and children | 16 |
in of cases | 16 |
in patients treated | 16 |
signs of respiratory | 16 |
liver failure patients | 16 |
severe or critical | 16 |
in southern china | 16 |
be found in | 16 |
the size of | 16 |
in a variety | 16 |
could not be | 16 |
of severe falciparum | 16 |
to the patient | 16 |
the first days | 16 |
with the severity | 16 |
and lack of | 16 |
could be used | 16 |
are required to | 16 |
a case report | 16 |
the synthesis of | 16 |
in the upper | 15 |
a small number | 15 |
outbreak in china | 15 |
in spite of | 15 |
diagnosis of sars | 15 |
early phase of | 15 |
in the lower | 15 |
use in the | 15 |
studies have demonstrated | 15 |
has been observed | 15 |
intravenous fluids and | 15 |
nonsteroidal antiinflammatory drugs | 15 |
seen in the | 15 |
the goal of | 15 |
severe pneumonia group | 15 |
are able to | 15 |
no difference in | 15 |
transmission of the | 15 |
infants and young | 15 |
adults hospitalized with | 15 |
data on the | 15 |
has to be | 15 |
this is the | 15 |
expression of ace | 15 |
reported that the | 15 |
was detected in | 15 |
in liver failure | 15 |
disease severity in | 15 |
those with severe | 15 |
chronic severe hepatitis | 15 |
lung injury by | 15 |
or in the | 15 |
severe liver disease | 15 |
the range of | 15 |
severe or complicated | 15 |
for the presence | 15 |
of liver function | 15 |
so as to | 15 |
hepatic encephalopathy in | 15 |
obtained from the | 15 |
risk of infection | 15 |
igm and igg | 15 |
more severe disease | 15 |
of the cytokine | 15 |
common causes of | 15 |
type i and | 15 |
of acute respiratory | 15 |
of the major | 15 |
receptor for sars | 15 |
an independent risk | 15 |
contributed to the | 15 |
severe critical cases | 15 |
study of the | 15 |
coronavirus infection in | 15 |
cardiovascular and respiratory | 15 |
sure that the | 15 |
have been observed | 15 |
large amounts of | 15 |
of cerebral malaria | 15 |
center for disease | 15 |
spontaneous bacterial peritonitis | 15 |
to the use | 15 |
at higher risk | 15 |
based on a | 15 |
inflammatory response in | 15 |
at increased risk | 15 |
and viral load | 15 |
of liver injury | 15 |
between the groups | 15 |
version posted march | 15 |
in the general | 15 |
this may be | 15 |
likely to have | 15 |
risk of mortality | 15 |
clinical manifestations and | 15 |
mortality rate was | 15 |
is no known | 15 |
cancer drug manual | 15 |
infection in the | 15 |
influenza a h | 15 |
inflammatory syndrome in | 15 |
we do not | 15 |
infection in a | 15 |
can cause a | 15 |
admission to the | 15 |
occurs in the | 15 |
on physical examination | 15 |
drug of choice | 15 |
t cells are | 15 |
with mechanical ventilation | 15 |
a cohort of | 15 |
a cytokine storm | 15 |
in this group | 15 |
also been reported | 15 |
patients who died | 15 |
have been found | 15 |
emergency use authorization | 15 |
severe hepatitis is | 15 |
the epidemiology of | 15 |
if an animal | 15 |
innate immune responses | 15 |
of severe maternal | 15 |
of a new | 15 |
with and without | 15 |
primary cause of | 15 |
malaria in the | 15 |
the design of | 15 |
due to their | 15 |
of the illness | 15 |
functional exhaustion of | 15 |
extracorporeal membrane oxygenation | 15 |
of the manuscript | 15 |
days of illness | 15 |
an attempt to | 15 |
cytokines such as | 15 |
the authors declare | 15 |
human monoclonal antibody | 15 |
first case of | 15 |
the upper respiratory | 15 |
dependent rna polymerase | 15 |
fluid bolus therapy | 15 |
the group of | 15 |
in the uk | 15 |
in the human | 15 |
data from the | 15 |
high incidence of | 15 |
can be detected | 15 |
was seen in | 15 |
into the vessel | 15 |
were used to | 15 |
critical care medicine | 15 |
of the cases | 15 |
with an increased | 15 |
after the initial | 15 |
seem to be | 15 |
higher than that | 15 |
of inflammatory mediators | 15 |
pneumonia caused by | 15 |
mg kg q | 15 |
multivariate logistic regression | 15 |
two or more | 15 |
in the literature | 14 |
first week of | 14 |
we suggest that | 14 |
estimated to be | 14 |
to predict the | 14 |
to rule out | 14 |
activated partial thromboplastin | 14 |
likely to develop | 14 |
arterial blood pressure | 14 |
some patients with | 14 |
the lung and | 14 |
are characterized by | 14 |
of the total | 14 |
independently associated with | 14 |
zheng et al | 14 |
in line with | 14 |
parts of the | 14 |
the included studies | 14 |
to note that | 14 |
be beneficial in | 14 |
the most commonly | 14 |
liver failure in | 14 |
higher incidence of | 14 |
and lead to | 14 |
of severe or | 14 |
view of the | 14 |
activity against sars | 14 |
follow this procedure | 14 |
with sterile saline | 14 |
of sars is | 14 |
our understanding of | 14 |
several studies have | 14 |
complications such as | 14 |
location of the | 14 |
to that of | 14 |
demonstrated that the | 14 |
was carried out | 14 |
or orogastric lavage | 14 |
report of cases | 14 |
can be associated | 14 |
and the risk | 14 |
be considered for | 14 |
crystalloid fluids to | 14 |
of patients had | 14 |
majority of the | 14 |
approved by the | 14 |
the nlrp inflammasome | 14 |
adverse effects of | 14 |
a monoclonal antibody | 14 |
length of stay | 14 |
a significant increase | 14 |
hospitalized with severe | 14 |
strongly associated with | 14 |
the patient can | 14 |
retrospective study of | 14 |
and duration of | 14 |
was performed in | 14 |
chinese center for | 14 |
and t cell | 14 |
in patients receiving | 14 |
is consistent with | 14 |
was used for | 14 |
in the acute | 14 |
mortality of covid | 14 |
oral administration of | 14 |
of septic shock | 14 |
with severe or | 14 |
evidence of a | 14 |
because of its | 14 |
of liver cell | 14 |
leading to the | 14 |
defined as a | 14 |
that the incidence | 14 |
spike protein of | 14 |
renal failure in | 14 |
be performed to | 14 |
human immunodeficiency virus | 14 |
may be due | 14 |
difference between the | 14 |
effect of the | 14 |
virus infection in | 14 |
in the last | 14 |
been used in | 14 |
standard of care | 14 |
have been associated | 14 |
and critically ill | 14 |
the timing of | 14 |
can be a | 14 |
for the first | 14 |
can be measured | 14 |
for critically ill | 14 |
were detected in | 14 |
and found that | 14 |
period of time | 14 |
a trial of | 14 |
present in the | 14 |
with poor prognosis | 14 |
be an important | 14 |
is a major | 14 |
plays an important | 14 |
there are several | 14 |
total number of | 14 |
positive pressure ventilation | 14 |
fresh whole blood | 14 |
a subset of | 14 |
the purpose of | 14 |
of a large | 14 |
as long as | 14 |
respiratory tract infection | 14 |
vomiting and diarrhea | 14 |
can be seen | 14 |
with a new | 14 |
a constant rate | 14 |
severe disease in | 14 |
removal of the | 14 |
is found in | 14 |
in children in | 14 |
we did not | 14 |
red blood cell | 14 |
it is likely | 14 |
the treatment for | 14 |
sars in the | 14 |
of acute liver | 14 |
is an acute | 14 |
of the eye | 14 |
risk of asthma | 14 |
organ dysfunction syndrome | 14 |
regulatory t cells | 14 |
effect on the | 14 |
differences between the | 14 |
horses with mild | 14 |
is the main | 14 |
that could be | 14 |
after the first | 14 |
levels of pro | 14 |
the severe critical | 14 |
to be an | 14 |
ventilation may be | 14 |
coronavirus pneumonia in | 14 |
administer intravenous crystalloid | 14 |
patient with severe | 14 |
in the use | 14 |
infected by sars | 14 |
than those in | 14 |
active ingredient in | 14 |
severity and mortality | 14 |
in the dog | 14 |
patients with pneumonia | 14 |
described in the | 14 |
randomized clinical trials | 14 |
use of tocilizumab | 14 |
be necessary to | 14 |
the outbreak of | 14 |
cm h o | 14 |
a and b | 14 |
in up to | 14 |
multisystem inflammatory syndrome | 14 |
acquired pneumonia in | 14 |
common cause of | 14 |
be required to | 14 |
compared to other | 14 |
has been a | 13 |
effectiveness of convalescent | 13 |
studies showed that | 13 |
renal replacement therapy | 13 |
central venous catheter | 13 |
have demonstrated that | 13 |
suggested that the | 13 |
or more of | 13 |
treatment of acute | 13 |
with evidence of | 13 |
is the active | 13 |
from january to | 13 |
to the intensive | 13 |
hepatic encephalopathy and | 13 |
months to years | 13 |
with moderate to | 13 |
the rest of | 13 |
of respiratory viruses | 13 |
diseases such as | 13 |
of severe fever | 13 |
natural history of | 13 |
analysis of sars | 13 |
can be given | 13 |
in conjunction with | 13 |
at risk of | 13 |
and immunogenicity of | 13 |
of severe respiratory | 13 |
of infection and | 13 |
mortality rate in | 13 |
of the three | 13 |
with pneumonia in | 13 |
large amount of | 13 |
with acute liver | 13 |
dependent on the | 13 |
reported in the | 13 |
be the most | 13 |
is largely supportive | 13 |
of patients were | 13 |
of infection in | 13 |
the most severe | 13 |
severe coronavirus disease | 13 |
were reported to | 13 |
cytokine storm in | 13 |
is responsible for | 13 |
of the affected | 13 |
in the analysis | 13 |
severe acute lung | 13 |
has been found | 13 |
well as in | 13 |
need for mechanical | 13 |
consistent with the | 13 |
through the skin | 13 |
it is believed | 13 |
b virus infection | 13 |
prospective observational study | 13 |
is mediated by | 13 |
disease in the | 13 |
the upper airways | 13 |
a majority of | 13 |
is believed to | 13 |
the first h | 13 |
caused by severe | 13 |
the catheter hub | 13 |
paediatric intensive care | 13 |
the lungs of | 13 |
at this time | 13 |
is contraindicated in | 13 |
injury to the | 13 |
of liver transplantation | 13 |
the active ingredient | 13 |
patients had a | 13 |
sensitivity and specificity | 13 |
no differences in | 13 |
significant differences in | 13 |
the burden of | 13 |
not appear to | 13 |
indicated that the | 13 |
the abdominal cavity | 13 |
in a cohort | 13 |
of hbv infection | 13 |
pathogenesis of sars | 13 |
african children with | 13 |
the performance of | 13 |
diagnosis of severe | 13 |
sars coronavirus in | 13 |
binding to the | 13 |
from the chinese | 13 |
other viral infections | 13 |
partial thromboplastin time | 13 |
of the heart | 13 |
is no evidence | 13 |
tissue plasminogen activator | 13 |
high prevalence of | 13 |
as a treatment | 13 |
at all times | 13 |
is shown in | 13 |
data of patients | 13 |
with a higher | 13 |
cytokine storm and | 13 |
to explore the | 13 |
for the patient | 13 |
to the level | 13 |
contact with the | 13 |
minimal hepatic encephalopathy | 13 |
transjugular intrahepatic portosystemic | 13 |
as compared with | 13 |
are related to | 13 |
patients with ascites | 13 |
natural killer cells | 13 |
an outbreak of | 13 |
of the tube | 13 |
and icu admission | 13 |
there is also | 13 |
is a key | 13 |
in patients in | 13 |
place an intravenous | 13 |
was the most | 13 |
there is evidence | 13 |
pulmonary vascular dilatation | 13 |
also known as | 13 |
been suggested that | 13 |
to those with | 13 |
acute phase of | 13 |
and has a | 13 |
in one study | 13 |
randomized controlled trials | 13 |
secondary hemophagocytic lymphohistiocytosis | 13 |
congenital heart disease | 13 |
blood urea nitrogen | 13 |
those patients who | 13 |
of tocilizumab in | 13 |
tumour necrosis factor | 13 |
with severe liver | 13 |
patients have been | 13 |
renal blood flow | 13 |
int csr sars | 13 |
fast respiratory rate | 13 |
and death in | 13 |
activity of the | 13 |
the transmission of | 13 |
depend on the | 13 |
airway epithelial cells | 13 |
in the cat | 13 |
that it is | 13 |
attributed to the | 13 |
treatment of the | 13 |
arterial blood gas | 13 |
should be taken | 13 |
chronic lung disease | 13 |
were higher in | 13 |
compared to those | 13 |
different types of | 13 |
pneumonia in the | 13 |
of falciparum malaria | 13 |
data were collected | 13 |
we believe that | 13 |
systemic levels of | 13 |
in the us | 13 |
the drug of | 13 |
in the world | 13 |
mortality in the | 13 |
index of suspicion | 13 |
uncomplicated falciparum malaria | 13 |
as a therapeutic | 13 |
has been proposed | 13 |
gastroprotectant and antiemetic | 13 |
and control of | 13 |
not been reported | 13 |
than that in | 13 |
prognosis in patients | 13 |
cases from the | 13 |
it is the | 13 |
of liver cells | 13 |
therapy in the | 13 |
with the use | 13 |
and prognosis of | 13 |
in the following | 13 |
hospitalized with covid | 13 |
and mortality of | 13 |
the chinese center | 13 |
with cirrhosis and | 13 |
remain to be | 13 |
the mechanisms of | 13 |
such as chronic | 13 |
pressure of oxygen | 13 |
severe critical progression | 13 |
of the same | 13 |
zhou et al | 13 |
that of the | 13 |
occur in the | 13 |
more susceptible to | 13 |
patients with suspected | 13 |
elevated lactate dehydrogenase | 13 |
liver failure and | 13 |
and clinical features | 13 |
of this article | 13 |
lower in the | 13 |
and characterization of | 13 |
of the wound | 13 |
a pilot study | 13 |
the most frequent | 13 |
the severe and | 13 |
of the human | 13 |
result in a | 13 |
clinical progression and | 13 |
the prowess trial | 13 |
the diagnosis is | 13 |
infection by sars | 13 |
between severe and | 13 |
of cases with | 13 |
of the brain | 13 |
molecular weight heparin | 13 |
mortality due to | 13 |
in pregnant women | 13 |
with severe and | 13 |
q h for | 13 |
for the detection | 13 |
of patients admitted | 13 |
be detected in | 13 |
in adults hospitalized | 13 |
of h n | 13 |
of t cell | 12 |
of the complement | 12 |
of severe community | 12 |
as a possible | 12 |
implications for the | 12 |
study showed that | 12 |
clinical trials of | 12 |
of cases in | 12 |
should be placed | 12 |
of the high | 12 |
exacerbation of chronic | 12 |
a foreign body | 12 |
the data of | 12 |
severe malaria and | 12 |
syndrome coronavirus spike | 12 |
is likely that | 12 |
it is necessary | 12 |
caused by sars | 12 |
to minimize the | 12 |
due to its | 12 |
been detected in | 12 |
the severe cap | 12 |
of aspiration pneumonia | 12 |
could be a | 12 |
of pediatric patients | 12 |
compared to healthy | 12 |
hepatitis b patients | 12 |
and chemokines in | 12 |
than mm hg | 12 |
to develop severe | 12 |
to control seizures | 12 |
h n virus | 12 |
the adaptive immune | 12 |
purpose of this | 12 |
and gastroprotectant drugs | 12 |
repeated doses of | 12 |
out of the | 12 |
of the thorax | 12 |
in severe falciparum | 12 |
the recovery of | 12 |
low molecular weight | 12 |
cytokine storm syndrome | 12 |
all over the | 12 |
factors in the | 12 |
tissue distribution of | 12 |
distribution of ace | 12 |
use of remdesivir | 12 |
liver cell damage | 12 |
successfully treated with | 12 |
might lead to | 12 |
body mass index | 12 |
no known antidote | 12 |
of antiviral drugs | 12 |
the characteristics of | 12 |
prospective study of | 12 |
a role for | 12 |
to the lungs | 12 |
analysis was performed | 12 |
age of the | 12 |
in the prowess | 12 |
the liver is | 12 |
effects of the | 12 |
an inability to | 12 |
ventilation blood flow | 12 |
is believed that | 12 |
of corticosteroids in | 12 |
defined by the | 12 |
mortality rate of | 12 |
prognosis of severe | 12 |
with mild covid | 12 |
the cardiovascular system | 12 |
the percentage of | 12 |
the symptoms of | 12 |
mild to severe | 12 |
for liver transplantation | 12 |
characterized by the | 12 |
sensitive and specific | 12 |
as early as | 12 |
observed in covid | 12 |
kg minute iv | 12 |
that can cause | 12 |
of the acute | 12 |
high viral load | 12 |
may reduce the | 12 |
in cerebral malaria | 12 |
to support the | 12 |
liver failure is | 12 |
can also occur | 12 |
the association of | 12 |
emesis or orogastric | 12 |
liver disease and | 12 |
diagnosis of malaria | 12 |
avian influenza a | 12 |
in china and | 12 |
administer activated charcoal | 12 |
may have been | 12 |
of femoral head | 12 |
memory t cells | 12 |
mesenchymal stem cells | 12 |
results from a | 12 |
spread of sars | 12 |
in a community | 12 |
levels in the | 12 |
used to assess | 12 |
acute hepatitis b | 12 |
deep vein thrombosis | 12 |
prospective cohort study | 12 |
a case series | 12 |
is common in | 12 |
yang et al | 12 |
at high risk | 12 |
respiratory syndrome clinical | 12 |
immune responses and | 12 |
or complicated malaria | 12 |
such as fever | 12 |
first days of | 12 |
the small intestine | 12 |
have been identified | 12 |
with the exception | 12 |
of all patients | 12 |
patients with pulmonary | 12 |
viral infection in | 12 |
different stages of | 12 |
immune system is | 12 |
binding of the | 12 |
blood gas analysis | 12 |
factor in the | 12 |
electronic medical records | 12 |
of innate immunity | 12 |
of renal failure | 12 |
the spectrum of | 12 |
resulting in a | 12 |
of a randomized | 12 |
in a pediatric | 12 |
of cytokines and | 12 |
on the efficacy | 12 |
are involved in | 12 |
also contribute to | 12 |
most common cause | 12 |
glomerular filtration rate | 12 |
respiratory failure in | 12 |
the clipped area | 12 |
this this version | 12 |
lodged in the | 12 |
if clinical signs | 12 |
on the severity | 12 |
of the pandemic | 12 |
to understand the | 12 |
and critical covid | 12 |
in human airway | 12 |
and those who | 12 |
the evaluation of | 12 |
the distribution of | 12 |
administer supplemental oxygen | 12 |
median duration of | 12 |
centers for disease | 12 |
aspects of the | 12 |
treatment for covid | 12 |
community acquired pneumonia | 12 |
of infected patients | 12 |
of the chest | 12 |
the evolution of | 12 |
of severely ill | 12 |
differential diagnosis of | 12 |
reported in of | 12 |
an animal is | 12 |
observational study of | 12 |
to maintain the | 12 |
significant increase in | 12 |
therapy should be | 12 |
of the main | 12 |
lessons from the | 12 |
liver transplantation is | 12 |
place the patient | 12 |
dysregulation of immune | 12 |
mechanical ventilation may | 12 |
cases of novel | 12 |
it was found | 12 |
characteristics of covid | 12 |
of the above | 12 |
liver failure caused | 12 |
the virus and | 12 |
severe group than | 12 |
of symptoms and | 12 |
the primary cause | 12 |
may be used | 12 |
of viral rna | 12 |
a complete blood | 12 |
treatment of malaria | 12 |
for this this | 12 |
upper airway obstruction | 12 |
can increase the | 12 |
within to hours | 12 |
a randomized controlled | 12 |
in pidd patients | 12 |
inborn errors of | 12 |
treating patients with | 12 |
the exception of | 12 |
lung injury and | 12 |
with respect to | 12 |
most common clinical | 12 |
onset of fever | 12 |
the induction of | 12 |
were no significant | 12 |
minute iv cri | 12 |
high rates of | 12 |
upper gastrointestinal bleeding | 12 |
leads to the | 12 |
to the severe | 12 |
is supported by | 12 |
use of the | 12 |
case of covid | 12 |
to of patients | 12 |
are difficult to | 12 |
and review of | 12 |
and epidemiology of | 12 |
may be beneficial | 12 |
severity of liver | 12 |
of patients treated | 12 |
risk of causing | 12 |
patients with ards | 12 |
an important factor | 12 |
not able to | 12 |
in all cases | 12 |
of airway inflammation | 12 |
of pandemic influenza | 12 |
be able to | 12 |
and antiemetic drugs | 12 |
known to be | 12 |
is the only | 12 |
within to days | 12 |
to be further | 12 |
t cell response | 12 |
host immune response | 12 |
in the hospital | 12 |
this is an | 12 |
most of these | 12 |
the period of | 12 |
small animal patients | 12 |
yet to be | 12 |
may be helpful | 12 |
are found in | 12 |
in hepatic encephalopathy | 12 |
in the recovery | 12 |
which leads to | 12 |
for severe illness | 12 |
of action of | 12 |
liu et al | 12 |
may be involved | 12 |
patients with hps | 12 |
the point of | 12 |
often associated with | 12 |
of acute and | 12 |
is made based | 12 |
account for the | 12 |
the utility of | 12 |
to remove the | 12 |
mediated by the | 12 |
blood in the | 12 |
or may not | 12 |
the critically ill | 12 |
was a significant | 12 |
respiratory distress and | 12 |
in an attempt | 12 |
a high risk | 12 |
has been demonstrated | 12 |
of developing severe | 12 |
maintain hydration and | 12 |
central venous pressure | 12 |
in such cases | 12 |
as the primary | 12 |
for severe disease | 12 |
are known to | 12 |
from the coronavirus | 12 |
do not induce | 11 |
is essential to | 11 |
compared to patients | 11 |
during the initial | 11 |
of these drugs | 11 |
were excluded from | 11 |
case fatality rate | 11 |
vitro studies have | 11 |
the affected area | 11 |
chronic kidney disease | 11 |
of the upper | 11 |
outside of the | 11 |
is necessary for | 11 |
more than a | 11 |
the safety and | 11 |
type i interferons | 11 |
the location of | 11 |
clinical data and | 11 |
to ensure that | 11 |
to be due | 11 |
the brain and | 11 |
were more likely | 11 |
for the use | 11 |
ranging from to | 11 |
correction of the | 11 |
transmission of severe | 11 |
the lungs and | 11 |
quinine in the | 11 |
most patients with | 11 |
responses in patients | 11 |
use of antibiotics | 11 |
and is a | 11 |
mutations in the | 11 |
therapy may be | 11 |
bronchial epithelial cells | 11 |
or mechanical ventilation | 11 |
tocilizumab in patients | 11 |
have been proposed | 11 |
summary of a | 11 |
divided into two | 11 |
coronavirus from patients | 11 |
the second week | 11 |
a randomized trial | 11 |
respiratory tract and | 11 |
virus in the | 11 |
it is recommended | 11 |
the lymphocyte count | 11 |
after days of | 11 |
because of their | 11 |
in the diagnosis | 11 |
clinical signs may | 11 |
public health emergency | 11 |
efficacy of the | 11 |
the catheter site | 11 |
the assessment of | 11 |
of renal function | 11 |
mortality in covid | 11 |
severe equine asthma | 11 |
day after admission | 11 |
and more than | 11 |
is closely related | 11 |
if the animal | 11 |
week of illness | 11 |
syndrome severe acute | 11 |
patients diagnosed with | 11 |
the h n | 11 |
to the right | 11 |
apache ii score | 11 |
juvenile idiopathic arthritis | 11 |
been identified in | 11 |
with more severe | 11 |
in which a | 11 |
had a history | 11 |
clinical presentation of | 11 |
increased risk for | 11 |
the mainstay of | 11 |
lung function in | 11 |
on patients with | 11 |
be effective in | 11 |
from the gastrointestinal | 11 |
blood samples were | 11 |
malaria is a | 11 |
of sars cov | 11 |
not induce emesis | 11 |
important to note | 11 |
on u s | 11 |
in the short | 11 |
morbid neurological diseases | 11 |
food and drug | 11 |
a retrospective analysis | 11 |
is a very | 11 |
none of these | 11 |
the lower respiratory | 11 |
admitted to hospital | 11 |
innate lymphoid cells | 11 |
of angiotensin converting | 11 |
adjacent to the | 11 |
outcomes in patients | 11 |
progression to severe | 11 |
for early diagnosis | 11 |
reported to occur | 11 |
of the injury | 11 |
arterial partial pressure | 11 |
update on the | 11 |
we performed a | 11 |
total of patients | 11 |
for patients who | 11 |
the diagnostic criteria | 11 |
human cerebral malaria | 11 |
human airway epithelial | 11 |
included in this | 11 |
use of glucocorticoids | 11 |
a pneumonia outbreak | 11 |
cells in covid | 11 |
with susceptibility to | 11 |
are the main | 11 |
in light of | 11 |
patients with primary | 11 |
antiemetic and gastroprotectant | 11 |
previous studies have | 11 |
studies demonstrated that | 11 |
time to clinical | 11 |
the loss of | 11 |
were in the | 11 |
and chest ct | 11 |
was used in | 11 |
with a history | 11 |
analysis of cases | 11 |
suggesting that the | 11 |
and of the | 11 |
the host immune | 11 |
information on the | 11 |
may increase the | 11 |
to severe disease | 11 |
of participants receiving | 11 |
is a potent | 11 |
of cases from | 11 |
away from the | 11 |
in the s | 11 |
structure of the | 11 |
the risk for | 11 |
the urinary bladder | 11 |
and drug administration | 11 |
was reported to | 11 |
of the data | 11 |
viral replication and | 11 |
in the community | 11 |
compared to non | 11 |
the middle east | 11 |
to perform a | 11 |
an association between | 11 |
responses in severe | 11 |
to respiratory failure | 11 |
convalescent plasma for | 11 |
after onset of | 11 |
was higher in | 11 |
immune response and | 11 |
and receptor binding | 11 |
with hepatic encephalopathy | 11 |
coronavirus disease clinical | 11 |
variation in the | 11 |
is essential for | 11 |
leads to a | 11 |
for management of | 11 |
diagnosed with covid | 11 |
of red blood | 11 |
liver cirrhosis and | 11 |
a mouse model | 11 |
to the skin | 11 |
infection of the | 11 |
of middle east | 11 |
children and adolescents | 11 |
may occur in | 11 |
the care of | 11 |
diagnosis of covid | 11 |
taking care to | 11 |
loss of consciousness | 11 |
in more than | 11 |
numbers of patients | 11 |
in most patients | 11 |
a short period | 11 |
excluded from the | 11 |
that the levels | 11 |
has led to | 11 |
peripheral blood of | 11 |
is considered to | 11 |
an overview of | 11 |
mortality in severe | 11 |
kg body weight | 11 |
and prevention of | 11 |
studies have reported | 11 |
mean duration of | 11 |
and to the | 11 |
the action of | 11 |
is present in | 11 |
in one patient | 11 |
and electrolyte abnormalities | 11 |
of a report | 11 |
adult respiratory distress | 11 |
also be used | 11 |
safety and immunogenicity | 11 |
all patients were | 11 |
will need to | 11 |
safety and efficacy | 11 |
of the hpa | 11 |
a cluster of | 11 |
levels of cytokines | 11 |
is known as | 11 |
it is generally | 11 |
a length of | 11 |
are increased in | 11 |
low levels of | 11 |
intravenous catheter and | 11 |
be administered as | 11 |
in small animal | 11 |
of the toxin | 11 |
in any patient | 11 |
high rate of | 11 |
adaptive immune system | 11 |
with lopinavir ritonavir | 11 |
the appearance of | 11 |
predictors of mortality | 11 |
all the patients | 11 |
times a day | 11 |
which is the | 11 |
cells and cd | 11 |
factors for the | 11 |
identification of severe | 11 |
severe respiratory covid | 11 |
load in a | 11 |
of more than | 11 |
the patient may | 11 |
age of years | 11 |
a significantly higher | 11 |
the initiation of | 11 |
the united kingdom | 11 |
treated with tocilizumab | 11 |
risk factors and | 11 |
monitor the patient | 11 |
weeks to months | 11 |
the clinical signs | 11 |
into the systemic | 11 |
can be treated | 11 |
may or may | 11 |
is used in | 11 |
in of the | 11 |
levels of serum | 11 |
as it is | 11 |
are caused by | 11 |
all of them | 11 |
care to avoid | 11 |
of fresh frozen | 11 |
drugs to treat | 11 |
not significantly different | 11 |
and hepatic encephalopathy | 11 |
features of covid | 11 |
severe critical group | 11 |
significantly lower in | 11 |
on the management | 11 |
may be useful | 11 |
lower levels of | 11 |
binding lectin in | 11 |
cohort of patients | 11 |
treatment of a | 11 |
to other causes | 11 |
rule of twenty | 11 |
the disease in | 11 |
would like to | 11 |
after liver transplantation | 11 |
which in turn | 11 |
of severe cap | 11 |
for to days | 11 |
the difference between | 11 |
revealed that the | 11 |
compassionate use of | 11 |
common in patients | 11 |
to the non | 11 |
the possibility that | 11 |
and use of | 11 |
be seen in | 11 |
spread of the | 11 |
poor prognosis in | 11 |
clinical signs include | 11 |
of ace expression | 11 |
in the cns | 11 |
as high as | 11 |
the clinical symptoms | 11 |
mg kg sq | 11 |
these patients were | 11 |
in severe cap | 11 |
and functional exhaustion | 11 |
for sars coronavirus | 11 |
signs of a | 11 |
severe disease or | 11 |
as an important | 11 |
to protect the | 11 |
in the immune | 11 |
been documented in | 11 |
exhaustion of t | 11 |
of clinical and | 10 |
this can be | 10 |
a community outbreak | 10 |
patients with hepatic | 10 |
the sars cov | 10 |
of fatal cases | 10 |
the beginning of | 10 |
analysis was used | 10 |
according to their | 10 |
mechanical ventilation was | 10 |
also lead to | 10 |
majority of cases | 10 |
of intracranial pressure | 10 |
is in the | 10 |
in infants with | 10 |
many patients with | 10 |
and chronic liver | 10 |
the median age | 10 |
response of the | 10 |
in the current | 10 |
mg kg im | 10 |
cases in the | 10 |
no competing interests | 10 |
followed by the | 10 |
associated with susceptibility | 10 |
those with mild | 10 |
is estimated to | 10 |
study of severe | 10 |
used in patients | 10 |
progression and viral | 10 |
authors declare that | 10 |
patients suffering from | 10 |
should be conducted | 10 |
on the presence | 10 |
new coronavirus of | 10 |
characteristics and outcomes | 10 |
and symptoms of | 10 |
are responsible for | 10 |
and response to | 10 |
asthma exacerbations and | 10 |
inflammatory responses in | 10 |
of an open | 10 |
severe hepatitis with | 10 |
the value of | 10 |